Dr. David Watson, MD
NPI: 1992779474
Total Payments
$234,178
2024 Payments
$19,701
Companies
38
Transactions
269
Medicare Patients
7,637
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$117,018 (50.0%)
Research$52,068 (22.2%)
Consulting$44,812 (19.1%)
Travel$10,200 (4.4%)
Food & Beverage$10,081 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,018 | 23 | 50.0% |
| Unspecified | $52,068 | 19 | 22.2% |
| Consulting Fee | $44,812 | 12 | 19.1% |
| Travel and Lodging | $10,200 | 37 | 4.4% |
| Food and Beverage | $10,081 | 178 | 4.3% |
Payments by Type
General
$182,110
250 transactions
Research
$52,068
19 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $155,250 | 154 | $0 (2024) |
| Corin USA | $31,725 | 12 | $0 (2019) |
| SI-BONE, INC. | $14,422 | 6 | $0 (2024) |
| OMNIlife science, Inc | $11,250 | 2 | $0 (2021) |
| F. Hoffmann-La Roche AG | $7,659 | 5 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $6,000 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,222 | 5 | $0 (2018) |
| PolyNovo North America LLC | $851.01 | 17 | $0 (2024) |
| Eli Lilly and Company | $450.00 | 1 | $0 (2020) |
| Stryker Corporation | $410.64 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,701 | 31 | Smith+Nephew, Inc. ($18,510) |
| 2023 | $22,953 | 39 | Smith+Nephew, Inc. ($17,599) |
| 2022 | $20,844 | 21 | SI-BONE, Inc. ($14,254) |
| 2021 | $33,759 | 37 | Smith+Nephew, Inc. ($19,492) |
| 2020 | $976.69 | 11 | Eli Lilly and Company ($450.00) |
| 2019 | $39,193 | 39 | Smith+Nephew, Inc. ($33,172) |
| 2018 | $81,956 | 52 | Smith & Nephew, Inc. ($56,890) |
| 2017 | $14,797 | 39 | Corin USA ($10,675) |
All Payment Transactions
269 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $162.43 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 12/04/2024 | Smith+Nephew, Inc. | TANDEM (Device) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Recon, Hip Primary | ||||||
| 11/26/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 11/12/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 10/31/2024 | Smith+Nephew, Inc. | EVOS (Device), Evos Mini, EVOS | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,400.00 | General |
| Category: Trauma Plates, Screws, and Nails | ||||||
| 10/30/2024 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $54.14 | General |
| 10/23/2024 | Smith+Nephew, Inc. | Evos Mini (Device), EVOS, TRIGEN | Food and Beverage | In-kind items and services | $54.33 | General |
| Category: Trauma Plates, Screws, and Nails | ||||||
| 10/22/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $41.73 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 10/22/2024 | Smith+Nephew, Inc. | Evos Mini (Device), EVOS, TRIGEN | Food and Beverage | In-kind items and services | $38.53 | General |
| Category: Trauma Plates, Screws, and Nails | ||||||
| 10/15/2024 | Bioventus LLC | EXOGEN ULTRASOUND BONE HEALING SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: DEVICES | ||||||
| 10/06/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 09/17/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $45.62 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 08/29/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $157.89 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 08/27/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 08/16/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 08/14/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $57.60 | General |
| 08/02/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $116.23 | General |
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $47.61 | General |
| 07/18/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 07/15/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 07/13/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $92.22 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 06/18/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 06/11/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 06/09/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| COC | Corin USA | $31,275 | 11 |
| A Prospective, comparative, randomized, single blind, multi-center study of the Trinity Biolox delta ceramic-on-ceramic total hip replacement system vs Trinity Acetabular hip System | OMNIlife science, Inc | $11,250 | 2 |
| ACP-103-032 | ACADIA Pharmaceuticals Inc | $6,000 | 1 |
| Study to Qualify a Biomarker to Identify Subjects at Risk for MCI due to AD and to Evaluate Efficacy and Safety of Pioglitazone in Delaying Onset of MCI due to AD | Takeda Pharmaceuticals U.S.A., Inc. | $3,093 | 4 |
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $450.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,111 | 5,274 | $2.2M | $307,788 |
| 2022 | 29 | 1,908 | 22,731 | $2.1M | $301,198 |
| 2021 | 24 | 1,940 | 19,112 | $2.0M | $281,439 |
| 2020 | 21 | 1,678 | 4,155 | $1.3M | $206,652 |
Total Patients
7,637
Total Services
51,272
Medicare Billing
$1.1M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 465 | 772 | $494,080 | $68,198 | 13.8% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2023 | 52 | 54 | $390,420 | $52,648 | 13.5% |
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2023 | 40 | 42 | $303,240 | $43,052 | 14.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 200 | 352 | $141,150 | $18,461 | 13.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 114 | 129 | $117,390 | $16,351 | 13.9% |
| 27132 | Total hip replacement after previous hip surgery | Facility | 2023 | 12 | 12 | $107,280 | $14,861 | 13.9% |
| 73503 | X-ray of hip, minimum of 4 views | Office | 2023 | 259 | 354 | $103,210 | $13,973 | 13.5% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 235 | 372 | $84,710 | $11,898 | 14.0% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 71 | 76 | $85,120 | $11,132 | 13.1% |
| 27245 | Treatment of broken neck of thigh bone with bone implant | Facility | 2023 | 11 | 11 | $71,830 | $10,438 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $75,650 | $10,247 | 13.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 41 | 41 | $45,920 | $6,192 | 13.5% |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2023 | 14 | 59 | $36,881 | $5,659 | 15.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 36 | $37,440 | $4,940 | 13.2% |
| 27093 | Injection of contrast for imaging of hip joint | Office | 2023 | 25 | 28 | $34,800 | $4,227 | 12.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 38 | $17,480 | $2,603 | 14.9% |
| 73525 | Review by radiologist of hip joint image | Office | 2023 | 25 | 30 | $20,100 | $2,528 | 12.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 187 | 2,517 | $15,104 | $2,052 | 13.6% |
| 73552 | X-ray of thigh bone, minimum 2 views | Office | 2023 | 46 | 66 | $10,970 | $1,603 | 14.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 17 | 18 | $10,440 | $1,534 | 14.7% |
| 77073 | X-ray for bone length assessment | Office | 2023 | 30 | 32 | $7,360 | $1,025 | 13.9% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 22 | 41 | $6,810 | $986.17 | 14.5% |
| 73523 | X-ray of both hips, minimum of 5 views | Office | 2023 | 25 | 25 | $7,750 | $942.44 | 12.2% |
| 73522 | X-ray of both hips, 3-4 views | Office | 2023 | 19 | 20 | $5,400 | $777.86 | 14.4% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 11 | 24 | $4,880 | $694.36 | 14.2% |
About Dr. David Watson, MD
Dr. David Watson, MD is a Adult Reconstructive Orthopaedic Surgery healthcare provider based in Temple Terrace, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992779474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Watson, MD has received a total of $234,178 in payments from pharmaceutical and medical device companies, with $19,701 received in 2024. These payments were reported across 269 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($117,018).
As a Medicare-enrolled provider, Watson has provided services to 7,637 Medicare beneficiaries, totaling 51,272 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Reconstructive Orthopaedic Surgery
- Other Specialties Orthopaedic Trauma, Orthopaedic Surgery
- Location Temple Terrace, FL
- Active Since 02/14/2006
- Last Updated 03/26/2025
- Taxonomy Code 207XS0114X
- Entity Type Individual
- NPI Number 1992779474
Products in Payments
- EVOS (Device) $27,735
- Anthology (Device) $26,959
- POLARCUP (Device) $23,606
- IFUSE IMPLANT (Device) $14,090
- Oxinium Hips (Device) $13,388
- JOURNEY II (Device) $11,343
- REDAPT Revision Hip System (Device) $10,026
- JOURNEY II BCS (Device) $6,188
- NUPLAZID (Drug) $6,000
- OR3O Dual Mobility (Device) $4,649
- Actos (Drug) $3,157
- JII Unicondylar Knee System (Device) $3,010
- POLAR3 (Device) $2,700
- TANDEM (Device) $2,700
- Journey II XR (Device) $2,649
- REDAPT (Device) $2,439
- REAL INTELLIGENCE (Device) $1,417
- Legion Revision (Device) $1,227
- VERILAST Hips (Device) $964.72
- NOVOSORB BTM (Device) $851.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Reconstructive Orthopaedic Surgery Doctors in Temple Terrace
Thomas Bernasek, Md, MD
Adult Reconstructive Orthopaedic Surgery — Payments: $8.0M
Adult Reconstructive Orthopaedic Surgery $8.0M
Kenneth Gustke, Md, MD
Adult Reconstructive Orthopaedic Surgery — Payments: $5.4M
Adult Reconstructive Orthopaedic Surgery $5.4M
Brian Palumbo, Md, MD
Adult Reconstructive Orthopaedic Surgery — Payments: $322,199
Adult Reconstructive Orthopaedic Surgery $322,199
Grant Garlick, Md, MD
Adult Reconstructive Orthopaedic Surgery — Payments: $8,884
Adult Reconstructive Orthopaedic Surgery $8,884